Art Director / Illustrator

Innovative Treatments

GBT Data Presentations at 60th American Society of Hematology (ASH) Annual Meeting & Exposition in San Diego, California.

GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its late-stage product candidate, voxelotor (previously called GBT440), for the treatment of sickle cell disease.